Related by context. All words. (Click for frequent words.) 75 fatal myocardial infarction 74 nonfatal myocardial infarction 73 myocardial infarction stroke 72 nonfatal stroke 71 fatal hemorrhagic 70 nonfatal myocardial infarction MI 70 CNS systemic embolism 70 ventricular tachycardia VT 70 unstable angina pectoris 70 Erythropoietic therapies may 69 recurrent ischemia 69 reinfarction 69 events MACE 69 nonfatal MI 69 ipsilateral stroke 69 ST elevation myocardial 69 sustained ventricular tachycardia 68 myocardial infarction MI 68 HF hospitalization 68 Ischemic strokes 68 PLX STROKE targeting 68 urgent coronary revascularization 68 coronary revascularization 67 Hemorrhagic strokes 67 cerebrovascular events 67 coronary revascularization procedures 67 non valvular atrial 67 repeat revascularization 67 myocardial infarction ventricular fibrillation 67 coronary revascularisation 67 Angiograms carry slight 66 CHD CVD 66 Myocardial infarction 66 stroke transient ischemic 66 pyrexia mucositis sepsis febrile 66 stroke myocardial infarction 65 VT VF 65 Idiopathic pulmonary fibrosis IPF 65 cardiovascular hospitalization 65 refractory ischemia 65 cardiovascular hospitalizations 65 arterial thromboembolic events 65 lethal arrhythmias 65 infarction NSTEMI 65 ischemic cardiomyopathy 65 ventricular fibrillation VF 65 acute myocardial infarction AMI 65 Operative mortality 64 LV dysfunction 64 LVSD 64 segment elevation myocardial 64 ischemia driven 64 NSTEMI 64 TEAEs 64 MACCE 64 Uncontrolled hypertension 64 symptomatic VTE 64 dysrhythmias 64 periprocedural 64 Ischemic stroke 64 systemic embolism 64 Hemorrhagic stroke 64 target lesion revascularization 64 Vascular dementia 63 ST Segment Elevation 63 hypopneas 63 recurrent myocardial infarction 63 Intracerebral hemorrhage 63 hypertension congestive heart 63 NYHA Class II 63 angina myocardial infarction 63 nonischemic 63 Atrial flutter 63 revascularization procedures 63 rebleeding 63 Atrial fibrillation AF 63 revascularization procedure 63 prolonged QT interval 63 variant angina 63 myocardial infarctions 63 silent ischemia 63 TAXUS p value 63 Severe hypoglycemia 63 STEMIs 63 fibrinolysis 63 hypoxemia 63 death reinfarction 63 composite endpoint 63 cerebrovascular accident 63 severe exacerbations 63 atherothrombotic disease 63 nonfatal pulmonary embolism 62 pulmonary embolism PE 62 morphometric vertebral fractures 62 Ventricular tachycardia 62 receiving XGEVA 62 cardiac dysfunction 62 proximal DVT 62 irregular quivering 62 valvular disease 62 recurrent DVT 62 noncardiovascular mortality 62 carotid artery blockage 62 cardioembolic 62 acute decompensation 62 generalized edema 62 coronary intervention 62 vascular occlusive diseases 62 postoperative AF 62 perioperative mortality 62 torsade de pointes 62 ischemic complications 62 thrombotic events 62 angioplasty stenting 62 macrovascular events 62 decompensated heart failure 62 percutaneous intervention 62 undergoing CABG 62 intracranial hemorrhage ICH 62 acute ischemic 62 either ischemic clog 62 nonfatal cardiac arrest 61 revascularizations 61 Severe hypersensitivity reactions 61 necrotizing pancreatitis 61 hepatorenal syndrome 61 VIIBRYD 61 Tasigna prolongs 61 Infusion Reactions Severe 61 recurrent venous thromboembolism 61 Hypotension 61 included exfoliative dermatitis 61 recurrent VTE 61 aneurysm ruptures 61 neutropenia dehydration dyspnea 61 Lupus nephritis 61 thromboembolism 61 C1 INH deficiency 61 nonfasting triglyceride levels 61 ventricular tachyarrhythmia 61 thrombocytopenic 61 atrial tachyarrhythmias 61 Warfarin Coumadin 61 binary restenosis 61 gastrointestinal GI motility disorders 61 myocardial infarction 61 nonfatal cardiovascular 61 Renal impairment 61 Renal dysfunction 61 Cardiopulmonary bypass 61 Venous thromboembolism 61 chronic metabolic acidosis 61 symptomatic pulmonary embolism 61 antiplatelet drugs 61 symptomatic hyponatremia 61 echocardiographic parameters 61 coagulopathy 61 seizures miscarriages 61 asystole 61 cancerous enlargement 61 percutaneous transluminal coronary angioplasty 61 Postoperative complications 61 resynchronization therapy 61 unknown etiology 61 NNT = 61 angioplasties stents 61 cytopenias 61 antiplatelet medications 61 Anaphylactic reactions 61 peri procedural 61 fatal pulmonary embolism 61 Lactic acidosis 60 deCODE AF TM 60 intraoperative complications 60 airway obstruction bronchospasm stridor 60 noncardiac 60 de ath 60 rhythm abnormalities 60 hemorrhagic complications 60 Stent thrombosis 60 Relapsing remitting MS 60 thromboembolic events 60 aspirin clopidogrel 60 cardioembolic stroke 60 amputation blindness 60 acute myocardial infarctions 60 neurologic complications 60 intraventricular hemorrhage 60 recurrent ischemic 60 defibrillator CRT D 60 Endothelial dysfunction 60 preserved ejection fraction 60 kidney urologic 60 reinterventions 60 apnea hypopnea index 60 myocardial reperfusion 60 Primary endpoints 60 convulsive seizures 60 unstable angina UA 60 Febrile neutropenia 60 revascularisation 60 serum aminotransferase levels 60 colorectal adenoma 60 hoarseness urticaria hypotension 60 hematologic adverse 60 unstable angina 60 target vessel revascularization 60 β blockers 60 untreated OSA 60 CVD mortality 60 lung cancer NSCLC 60 Subclinical hypothyroidism 60 stroke hypertension palpitations 60 malperfusion 60 cardiogenic shock 60 atrioventricular block 60 intracranial atherosclerosis 60 carcinoids 60 Pulmonary embolism 60 pulmonary dysfunction 60 cardiac resynchronisation therapy 60 Alzheimer disease vascular dementia 60 Unstable angina 60 System IPSS 60 inhospital 60 fractional shortening 60 Diabetic nephropathy 60 drug eluting stent implantation 60 infarctions 60 intracerebral hemorrhages 60 lipid lowering agents 60 deep venous thromboses 60 torsades de pointes 60 left ventricular dysfunction 60 arterial revascularization 60 hepatic failure 60 SSc 60 intracerebral haemorrhage 60 Ribavirin causes 60 progressive dyspnea 60 prespecified secondary 60 ventricular tachyarrhythmias 59 patients undergoing percutaneous 59 prasugrel uh prevented 59 emphysema chronic bronchitis 59 primidone 59 thromboembolic 59 haematologic 59 cirrhosis liver failure 59 glycated hemoglobin levels 59 electrical cardioversion 59 XIENCE V PROMUS Stent 59 neutropenia thrombocytopenia 59 ventricular arrhythmia 59 pericardial mesothelioma 59 upper gastrointestinal bleeding 59 Subarachnoid hemorrhage 59 death dissection perforation 59 definite stent thrombosis 59 periprocedural MI 59 ICD implantation 59 angiographic restenosis 59 antithrombotic therapies 59 pericardial effusion 59 angina congestive heart 59 cryptogenic 59 fatal arrhythmic 59 anaphylactic reactions bronchospasm 59 chronic thromboembolic pulmonary 59 Cardiac arrhythmias 59 TAXUS Express Stent 59 thromboembolic complications 59 lightheadedness fainting 59 acute myocardial infarction 59 FluCAM arm 59 systemic autoimmune 59 Aortic stenosis 59 dyslipidemia hypertension diabetes 59 mild renal insufficiency 59 serum phosphorous 59 mucocutaneous reactions 59 neutropenic fever 59 infarction STEMI 59 carotid stenosis 59 neurologic sequelae 59 cerebrovascular ailments 59 myalgia arthralgia 59 QTc prolongation 59 XIENCE V demonstrated 59 prednisone prednisolone plus 59 hematologic toxicity 59 β blocker 59 PSA nadir 59 QTc intervals 59 affective psychoses 59 apnea hypopnea 59 J Antimicrob Chemother 59 elevation acute coronary 59 damage cirrhosis liver 59 Chronic renal failure 59 complement inhibitor eculizumab 59 drotrecogin alfa activated 59 thrombotic complications 59 cerebral infarction 59 noncardiovascular 59 Dilated cardiomyopathy 59 ischemic strokes 59 Pulmonary arterial hypertension 59 Peripheral arterial disease 59 malabsorptive 59 intra abdominal abscess 59 thrombolytic agents 59 histologic subtype 59 reoperations 59 pressure tachycardia diaphoresis 59 myocardial infarction congestive heart 59 CYT# potent vascular disrupting 59 hypertension hypercholesterolemia 59 NIHSS score 59 beta blockers ACE inhibitors 59 Acute pancreatitis 59 paroxysmal AF 59 Abdominal aortic aneurysms 59 primary percutaneous coronary 59 myocardial ischemia 59 Uncontrolled diabetes 59 vWD 59 atherosclerosis myocardial infarction 59 baseline serum creatinine 59 syndrome OSAS 59 Events MACE 59 laboratory abnormalities 59 cerebrovascular diseases 59 aplastic anemia AA 59 coronary stenosis 59 Acid reflux disease 59 hepato renal syndrome 59 events TEAEs 59 nausea dizziness vomiting 59 microvascular complications 59 Severe sepsis 59 Critical limb ischemia 59 wedge resection 59 EXJADE 59 AGGRASTAT R tirofiban hydrochloride 59 postoperative morbidity 59 TMP SMX 58 postoperative complication 58 haemorrhagic strokes 58 traumatic amputations 58 rhythm disturbances 58 prospectively stratified 58 liver decompensation 58 cervical spine fractures 58 Bilgena Read Terms 58 acute coronary syndromes ACS 58 embolic stroke 58 nonvascular 58 Arrhythmogenic Right Ventricular Cardiomyopathy 58 Ectopic pregnancy 58 cirrhosis scarring 58 mixed hyperlipidemia 58 Orthostatic hypotension 58 VTEs 58 ischemic cardiovascular 58 fatal IHD 58 Eisenmenger syndrome 58 peripheral arterial occlusive disease 58 thrombocytopenia anemia 58 myocardial infarctions MIs 58 Sleep disturbances 58 Obstructive sleep apnea 58 cerebrovascular accidents 58 anti arrhythmic drugs 58 ximelagatran 58 CTEPH 58 circulatory diseases 58 arrythmias 58 Thal Dex 58 coronary revascularizations 58 subarachnoid hemorrhages 58 Allergic asthma 58 radiochemotherapy 58 paroxysmal 58 metastatic GIST 58 heart palpitations dizziness 58 cerebral infarctions 58 anticoagulant warfarin 58 cardiogenic pulmonary edema 58 Untreated sleep apnea 58 thyrotoxicosis 58 undergoing coronary artery 58 Sezary syndrome 58 TIA transient ischemic 58 NMIBC 58 bleeding ulceration 58 systolic dysfunction 58 Peripheral neuropathies 58 COPD exacerbation 58 nonfatal myocardial infarctions 58 left ventricular systolic 58 nondiabetic patients 58 recombinant tissue plasminogen 58 deep vein thromboses 58 Hip fractures 58 Mitral valve repair 58 dilated cardiomyopathy DCM 58 Ischaemic heart 58 CV thrombotic 58 postoperative mortality 58 adjunctive ABILIFY 58 treat menorrhagia 58 Acute myocardial infarction 58 CK MB 58 undergoing coronary angiography 58 cerebral vasospasm 58 variceal 58 deCODE BreastCancer 58 electrophysiologic 58 Atopic eczema 58 cystic fibrosis chronic pancreatitis 58 acute coronary 58 atherothrombotic 58 tamoxifen Nolvadex ® 58 onset atrial fibrillation 58 dermatologic reactions 58 Coronary artery bypass grafting 58 Percutaneous coronary intervention 58 pulmonary artery banding 58 tissue oxygen saturation 58 Hb A1C 58 deCODE MI TM 58 bacterial prostatitis 58 postoperative atrial fibrillation 58 arterial calcification 58 PSVT 58 angiographic outcomes 58 leucopenia 58 elevated lipase 58 UPPP 58 hypercalcaemia 58 antiarrhythmic drug 58 Bacterial conjunctivitis 58 unstable angina chest 58 ARIXTRA 58 distal embolization thrombus formation 58 paroxysmal atrial fibrillation 58 Cynosure anticipates 58 thoracoscopic lobectomy 58 neurovascular diseases 58 renal dysfunction 58 thrombolytic therapy 58 proliferative retinopathy 58 hypertension diabetes mellitus 58 graft dysfunction 58 XIENCE V vs. 58 convulsions paralysis 58 perioperative complications 58 hyperacute 58 hypoventilation 58 lacunar 58 pacemaker implantation 58 myelofibrosis polycythemia vera 58 myocardial infraction 58 small lymphocytic lymphoma 58 Crohn Disease Activity 58 systemic corticosteroids 58 angina pectoris 58 sirolimus stent 58 airflow limitation 58 Balloon angioplasty 58 creatine kinase MB 58 neurologic impairment 58 undergo percutaneous coronary 58 multivessel disease 58 generalized tonic clonic seizures 58 anthracycline induced 58 serous ovarian cancer 58 adverse cytogenetics 58 oral hypoglycemic agents 58 adenomatous polyps 58 calcified plaques 58 Daytime sleepiness 58 mediastinitis 58 malignant neoplasm 58 EGFR mutation positive 58 cardiac tamponade cerebral edema 58 esophagogastric 58 thromboses 58 macrovascular complications 58 coronary stenoses 58 venous thromboembolisms 57 UA NSTEMI 57 recurrent glioblastoma multiforme 57 undergoing percutaneous coronary 57 CR nPR 57 laboratories ambulatory 57 catheter occlusion 57 affective psychosis 57 cryptogenic stroke 57 hemorrhagic bleeding 57 antithrombotic therapy 57 ruptured aneurysms 57 hypoglycemic events 57 scombroid poisoning 57 Autoimmune hepatitis 57 cisplatin gemcitabine 57 nontraumatic 57 intima media thickness 57 myoclonus 57 ejection fractions 57 Acute coronary syndromes 57 myocardial ischaemia 57 heparin induced thrombocytopenia 57 coronary artery clots 57 Farfan Juan Pablo 57 cerebral vascular 57 LOVENOX 57 bypass grafting 57 postintervention 57 paclitaxel eluting stents 57 Eligible PNPs 57 biologic DMARD 57 cardiovascular disease hypertension 57 cerebral vascular disease 57 receiving VELCADE 57 syncopal 57 Ischemic 57 generalized seizures 57 intracranial stenosis 57 Myocardial ischemia 57 curative resection 57 immunological reaction 57 induce orthostatic hypotension 57 alpha interferons 57 CHD mortality 57 Non inferiority 57 Adjuvant chemotherapy 57 PSADT 57 Coronary artery bypass graft 57 Acute lymphoblastic leukemia 57 del 5q MDS 57 psychiatric comorbidities 57 nadolol 57 Venous thromboembolism VTE 57 Acute renal failure 57 inhibit platelet function 57 asymptomatic carotid stenosis 57 secondary efficacy endpoint 57 KIF6 carriers 57 Hip fracture 57 hemorrhagic strokes 57 Index CDAI 57 Pleural mesothelioma 57 aortic valve stenosis 57 autonomic dysfunction 57 cerebral perfusion 57 events thrombocytopenia neutropenia 57 pancreatic resection 57 anginal pain 57 hypokalemia hypomagnesemia 57 Secondary endpoints included 57 tachyarrhythmia 57 extrapyramidal symptoms 57 sotalol 57 troponin T 57 Lumbar spinal stenosis 57 elevated LDH 57 spinal cord compression 57 NATRECOR R 57 venous thromboembolic disease 57 coma convulsions 57 Thalomid ® 57 multivariate adjustment 57 dopaminergic therapy 57 brand ciclesonide HFA 57 nicardipine 57 neutrophil counts 57 preserved systolic 57 stable angina pectoris 57 surgical revascularization 57 albumin excretion rate 57 cTnT 57 nonhematologic adverse reactions 57 anthracycline taxane 57 angina chest 57 STEMI ST 57 pain hypotension CVA 57 primary generalized tonic 57 Sleep disordered breathing 57 Peripheral artery disease 57 incidence ≥ 57 severe hypersensitivity reactions 57 arterial embolism 57 CI #.#-#.# [001] 57 HAM D# scores 57 intravenous RSD# 57 PRADAXA #mg 57 tirofiban 57 capillary leakage 57 insomnia somnolence 57 Myelosuppression 57 ZEVALIN therapeutic regimen 57 ACTOplus met XR 57 obj obj = 57 Ferlay J et al 57 conjunctival hyperemia 57 angiotensin converting enzyme inhibitors 57 contrast induced nephropathy 57 Percutaneous Transluminal Coronary Angioplasty 57 IIIa inhibitor 57 artery stenosis 57 artery occlusion 57 hypovolemic shock 57 Ischaemic stroke 57 bronchial hyperresponsiveness 57 pulmonary thromboembolism 57 pneumonia septicemia 57 renal insufficiency 57 Alzheimer disease narcolepsy 57 Sudden cardiac death 57 Ventricular fibrillation 57 neurologic dysfunction 57 anaphylactoid reactions 57 severe renal impairment 57 analgesic medications 57 Pulmonary hypertension 57 DVT PE 57 elevated triglyceride levels 57 pulmonary exacerbations 57 antiarrhythmic medications 57 rosuvastatin #mg 57 biochemical recurrence 57 microbiologically evaluable 57 arterial thromboembolic 57 transthoracic 57 peripheral sensory neuropathy 57 hypokalemia 57 reintervention 57 Abbott Trilipix 57 anastomotic devices 57 p = NS 57 hardened aortic valve 57 intraocular lenses IOLs phacoemulsification 57 TNF antagonist 57 bone marrow transplantations 57 erythema nodosum 57 Symptom onset 57 Carotid endarterectomy 57 histologies 57 Peripheral neuropathy 57 symptomatic intracranial 57 hypoperfusion 57 Idiopathic pulmonary fibrosis 57 dizziness nausea diarrhea 57 intracerebral hemorrhage ICH 57 Complication rates 57 acute coronary syndrome 57 Exacerbations 57 revascularized 57 metabolic alkalosis 57 antiphospholipid syndrome 57 CABG coronary artery 57 NYHA Class III 57 Vertebral fractures 57 IPAH 57 Chronic pancreatitis 57 ANCA associated 57 Oral mucositis 57 nonvertebral fracture 57 moderate renal impairment 56 either acutely decompensated 56 Plaque psoriasis 56 fluid overload 56 infliximab monotherapy 56 peripheral artery 56 Mitral regurgitation 56 Ileus 56 Uterine cancer 56 urgent revascularization 56 percutaneous coronary interventions 56 Inflammatory bowel disease 56 SCr 56 pyelonephritis 56 elevated fasting glucose 56 stent thromboses 56 diastolic blood pressures 56 Kaplan Meier curve 56 Radiofrequency ablation 56 Drug eluting stent 56 tachyarrhythmias 56 systemic corticosteroid 56 Obstructive sleep apnea OSA 56 elevated IOP 56 artery reclogging 56 aldosterone antagonist 56 intracerebral hemorrhage 56 AGGRASTAT ® tirofiban hydrochloride 56 0 & 56 candidemia 56 triglyceride concentration 56 sleeve lobectomy 56 Serious anaphylactoid reactions 56 distant metastasis 56 bronchopulmonary dysplasia 56 catheter angiography 56 malignant neoplasms 56 oxycodone IR 56 Thyroid disorders 56 syncope fainting 56 proliferative diabetic retinopathy 56 stage IIIb IV 56 apolipoprotein E4 56 Percutaneous Coronary Intervention 56 thyrotropin levels 56 androgen deprivation 56 benazepril 56 Retrograde ejaculation 56 Systemic lupus erythematosus 56 postoperative pulmonary 56 nonobstructive CAD 56 gastric cardia 56 macular edema secondary 56 Invasive fungal infections 56 Carotid artery disease 56 ID TLR 56 angiogenic therapy 56 QRS duration 56 anemia neutropenia 56 clot busting therapy 56 severe hypoglycemic 56 spirometric 56 fraction LVEF 56 Platinol ® cisplatin 56 squamous cell lung cancer 56 Acute Exacerbations 56 occlusive disease 56 locoregional recurrence 56 paroxysmal supraventricular tachycardia 56 glycoprotein IIb IIIa inhibitors 56 rituximab infusion 56 severe hypoglycaemia 56 interstitial pneumonitis 56 Prehypertension 56 oral hypoglycemic agent 56 Respiratory syncytial virus RSV 56 transfusion syndrome 56 impaired glucose metabolism 56 Systemic lupus erythematosus SLE 56 Metastatic breast cancer 56 repeat paracentesis 56 atrophic gastritis 56 prostate TURP 56 recurrent coronary 56 fainting lightheadedness 56 Cluster headaches 56 cardiac arrhythmia abnormal 56 intravascular sensors 56 chronic periodontitis 56 coronary stent merged 56 symptom exacerbation 56 recurrent wheezing 56 Secondary endpoints include 56 levodopa therapy 56 Elevated triglycerides 56 onset seizures 56 Airvana anticipates 56 infarcts 56 generator detaching 56 multi infarct dementia 56 hepatic cirrhosis 56 ventricular tachycardia 56 QRS interval 56 Arrhythmias 56 beta blocker therapy 56 stage IIIA 56 encephalitis meningitis 56 ischemic lesions 56 ARCOXIA 56 descending thoracic 56 achieved ACR# 56 somnolence dizziness 56 anaphylactoid 56 non selective NSAIDs 56 Degenerative disc disease 56 atrioventricular valve 56 obstructive coronary artery 56 preoperative intraoperative 56 eplerenone 56 asymptomatic PAD 56 reintubation 56 headache nasopharyngitis 56 NATRECOR ® 56 perinatal morbidity 56 Cardiac arrhythmia 56 antiplatelet therapies 56 stent implantation 56 transurethral resection 56 ATACAND 56 metastatic neuroendocrine tumors 56 severe mitral regurgitation 56 cardioverter defibrillator 56 gastrointestinal adverse reactions 56 nonalcoholic steatohepatitis 56 transaminase elevations 56 estimated glomerular filtration 56 NIASPAN 56 postoperative infections 56 tissue plasminogen activator tPA 56 internalizing disorders 56 veno occlusive disease 56 hypervascular tumors 56 ischemic 56 subclinical hypothyroidism 56 respiratory insufficiency 56 confusional arousals 56 macrovascular disease 56 Heavier loads 56 ischaemia 56 inotropic agents 56 colon resection 56 hyperkalemia 56 Hemiplegia 56 fibrinolytic therapy 56 % CI #.#-#.# [006] 56 revascularization 56 anticoagulants blood thinners 56 atherothrombotic events 56 Heavy menstrual bleeding 56 linaclotide treated 56 mitral regurgitation MR 56 aneurysmal subarachnoid hemorrhage 56 dysfunction LVSD 56 Kaplan Meier estimates 56 neutropenic patients 56 transcatheter closure 56 Conflicting casualty tolls 56 underwent angiography 56 See WARNINGS 56 prolonged immobilization 56 obstructive CAD 56 hypophosphatemia 56 ABCB1 56 patients undergoing CABG 56 vascular cognitive impairment 56 hemodynamically significant 56 serotonergic drugs 56 thrombo embolic 56 confidence interval #.#-#.# 56 ACTEMRA TM 56 Pulmonary edema 56 optic neuropathy 56 acute coronary syndromes 56 diabetic acidosis 56 bone marrow suppression 56 NSTE ACS 56 Uncontrolled asthma 56 nasopharyngitis headache 56 symptomatic atrial fibrillation 56 overt hepatic encephalopathy HE 56 malignant polyps 56 anticoagulation therapy 56 infective endocarditis 56 neutropaenia 56 intimal hyperplasia 56 IOP lowering 56 intracranial bleeding 56 VELCADE melphalan 56 hypercholesterolaemia 56 defibrillator implantation 56 origin PNH 56 Thrombolysis 56 Testosterone deficiency 56 treat brain aneurysms 56 Implantable cardioverter defibrillators 56 valvular heart disease 56 salmeterol HFA MDI 56 Chronic obstructive pulmonary 56 electrolyte abnormalities 56 MIs 56 mcg kg REBETOL 56 microvascular disease 56 underwent resection 56 vi ineffectiveness 56 bullous 56 CYPHER ® 56 replacement TAVR 56 beckhouse@californian.com 56 MI myocardial infarction 56 Atherosclerotic 56 ribavirin therapy 56 % CI #.#-#.# [004] 56 jclay@herald-leader.com 56 polypoid lesions 56 BYSTOLIC 56 lobectomy 56 Treatment emergent adverse 56 anthracycline containing 56 ADCS CGIC 55 LVEF 55 rehospitalization 55 Known hypersensitivity 55 Auxilium anticipates 55 #.#/#.# mmHg [001] 55 carotid revascularization 55 Waist Size 55 microangiopathy 55 multivariate Cox 55 cardiomyopathies 55 leiomyomas 55 CABG surgeries 55 postdischarge 55 MIRAPEX 55 ug dose 55 theglobe.com inc 55 thromboembolic disorders 55 x ULN 55 Colorectal cancers 55 PASI scores 55 Serious adverse reactions 55 microcirculatory improvement helping 55 supraventricular arrhythmias 55 BY JIM LAMBERT 55 EEG abnormalities 55 computed tomography angiography 55 tonic clonic movements 55 QT prolongation 55 hematopoietic cancers 55 Raabe Wizard 55 serum creatinine levels 55 Untreated diabetes 55 NPH insulin 55 HER2 overexpression 55 akinesia 55 discontinuations due 55 carotid atherosclerosis 55 Gestational diabetes 55 mitral insufficiency 55 headache abdominal pain 55 comorbid conditions 55 impaired hepatic 55 CP CPPS 55 unfractionated heparin UFH 55 postoperative bleeding 55 acid suppressive medication 55 oxycodone CR 55 hepatic insufficiency 55 Virologic failure 55 Myocardial Infarction MI 55 cbagley@californian.com 55 vein thrombosis 55 overt nephropathy 55 invasive angiography 55 Peritoneal mesothelioma 55 Discontinuations due 55 postoperative hemorrhage 55 thrombocytosis 55 cirrhotic 55 infarct size 55 thrombus aspiration 55 haemorrhagic stroke 55 wound dehiscence 55 Torsades de Pointes 55 intravesical infusion therapy 55 unprovoked seizures 55 Secca System 55 hyperpyrexia 55 pheochromocytoma 55 HBeAg negative 55 dermatologic toxicities 55 hyperalgesia 55 interstitial pneumonia 55 Heavy snorers 55 Ejection Fraction 55 OSAHS 55 Evidence Therapeutic study 55 diabetes dyslipidemia 55 renal artery stenosis 55 subarachnoid hemorrhage SAH 55 severe neutropenia 55 ventricular dysfunction 55 surgical aortic valve 55 pulmonary resection 55 cardiopulmonary bypass CPB 55 adjunctive placebo 55 rhythm abnormality 55 hemodynamic parameters 55 NYHA class 55 endometriosis ovarian cysts 55 Hypertrophic cardiomyopathy 55 cytoreductive surgery 55 transplantation HCT 55 Coronary artery calcification 55 Chronic bronchitis 55 gangrene amputation 55 stable angina 55 ischemic cerebrovascular 55 oral anticoagulation 55 bi ventricular pacing